Butler Pharmacy Wiki
Advertisement

This lecture by Dr. Kimberly Beck occurred on Wednesday, September 15th.

Study materials[]

Required reading: Golan: 469-472

Handouts[]

Panopto[]

Objectives[]

Describe which sites on the GnRH decapeptide are cleaved enzymatically in vivo and how this affects the half-life of this hormone.[]

Gonadotropin Releasing Hormone (GnRH) is enzymatically cleaved at two sites, which gives it a short half life in vivo of about 3-4 minutes. Either one or both of the will ultimately metabolize the hormone.

  • Between Tyrosine 5 and Glycine 6
  • Between Proline 9 and Glycine 10

Gonadotropin relesing hormone cleavage

Describe the rationale for the design of synthetic GnRH analogs.[]

Synthetic analogues of GnRH are designed to stabilize the protein against enzymatic attack and increase binding to the GnRH receptor

  • increasing the half life
  • increasing potency

Unfortunately since the drugs are peptides, they can't be given orally. They must be given parenteraly (IV, SubQ, Intranasally)

Describe the relevance of incorporating D-amino acids in GnRH analogs.[]

Normally all the amino acids used in the body are of the L-isomer form. But switching out the hydrophobic Glycine-6 with a D amino acid, it increases the half life of the GnRH analogue. Making the D-isomer of Glycine-6 bulky further increases receptor affinity. This increases potency 100-200x compared to natural GnRH

Describe the structure activity relationship of the GnRH agonists.[]

  • The PyroGlutamic adid 1, Histidine 2, and Tryptophan 3 are critical for biological potency of GnRH drugs.
  • Any substitutions or deletions of these three amino acids will decrease or abolish receptor binding activity.
  • When the glycine residue at position 6 is replaced with certain amino acids (combined with changes in the C-terminus) the proteolytic cleavage of the molecule is reduced, resulting in longer lasting action.
  • All of the synthetic analogues of GnRH have a half life of about 4 hours. Coupled with the marked increase in potency, they are called superagonists.

GnRH SAR

Describe the mechanism of action of the GnRH agonists.[]

Describe the structural features of the GnRH antagonists.[]

The GnRH antagonists

  • Are decapeptides, containing 10 amino acids
  • Usually have the first 3 amino acids modified from the original PyroGlu-His-Trp
  • Can contain up to 6 amino acid substitutions at the 1,2,3,6,8, and 10 positions.
  • Compounds usually contain 3-5 substitutions
  • The most potent antagonists (and there are only 2 available) contain the same D-amino acids at positions 1,2,3, and 10. The structural differences are at positions 6 and 8

Describe the mechanism of action of the GnRH antagonists.[]

Given the sequence or structure of a GnRH analog, recognize whether it is an agonist or antagonist.[]

Essentially a GnRH agonist will have identical residues to the first 3 of the natural compound. (PyroGlu-His-Trp) While an antagonist will have drastically different Ac-D-Nal(2)-D-Phe as its starting sequence

Compare and contrast the structures of somatostatin, octreotide, and lanreotide.[]

Advertisement